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Abstract
Platelets represent a target of reactive oxygen species produced under oxidative stress conditions. Controversial data on the
effect of these species on platelet functions have been reported so far. In this study we evaluated the effect of a wide range of
H2O2 concentrations on platelet adhesion to immobilized fibrinogen and on pp72syk and pp125FAK tyrosine
phosphorylation. Our results demonstrate that: (1) H2O2 does not affect the adhesion of unstimulated or apyrase-treated
platelets to immobilized fibrinogen; (2) H2O2 does not affect pp72syk phosphorylation induced by platelet adhesion to
fibrinogen-coated dishes; (3) H2O2 reduces, in a dose-dependent fashion, pp125FAK phosphorylation of fibrinogen-adherent
platelets ; (4) concentrations of H2O2 near to physiological values (10^12 WM) are able to strengthen the subthreshold
activation of pp125FAK induced by epinephrine in apyrase-treated platelets ; (5) H2O2 doses higher than 0.1 mM inhibit
ADP-induced platelet aggregation and dense granule secretion. The ability of H2O2 to modulate pp125FAK phosphorylation
suggests a role of this molecule in physiological hemostasis as well as in thrombus generation. ß 2000 Elsevier Science B.V.
All rights reserved.
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1. Introduction
For many years oxygen radicals and other oxygen-
derived species have been regarded as highly reactive
molecules which indiscriminately destroy biological
components. More recently, oxygen-derived species
gained attention as essential molecules that regulate
cell functions by modulating tyrosine phosphoryla-
tion-dependent signal transduction pathways [1^3].
Platelets are a potential target of reactive oxygen
species either produced under oxidative stress condi-
tions, such as in£ammation or ischemia^reperfusion
[4,5], or released by platelets themselves upon appro-
priate stimulation [6,7]. The relationship between re-
active oxygen species and platelet functions has been
extensively investigated [6]. However, the question
whether these species act as activators or inhibitors
of platelet functions remains unresolved, since largely
controversial results have been obtained depending
on the oxidant doses or the experimental conditions
employed. Several studies report that H2O2 does not
a¡ect or inhibit platelet aggregation [8,9], whereas
some authors found that H2O2 may enhance platelet
aggregation [10,11].
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Despite the large number of studies on the e¡ect of
oxidants on the process of platelet aggregation, few
data concerning their role in platelet adhesion have
been reported [12]. Platelet adherence to matrix pro-
teins, exposed in the damaged vessel wall or in the
ruptured atherosclerotic plaque, is, as well as aggre-
gation, a critical step in hemostasis and thrombosis.
Both platelet aggregation and adhesion are mediated
by KIIbL3, the most abundant and well characterized
platelet integrin receptor [13,14]. KIIbL3 can exist in
di¡erent activation states which can be distinguished
by the di¡erence in their ligand binding properties
[15,16]. The KIIbL3 form expressed on unstimulated
platelets can bind solid-phase ¢brinogen, but does
not bind the soluble form of ¢brinogen. Agonist
stimulation of platelets initiates a signal transduction
cascade, the so-called ‘inside-out’ signalling, which
leads to KIIbL3 conformational changes. This acti-
vated form of the integrin is able to bind both circu-
lating ¢brinogen and other adhesive proteins.
Furthermore, KIIbL3 participates in post-ligand
‘outside-in’ signalling which leads to platelet func-
tional response, that is aggregation or spreading
[17,18]. pp125FAK and pp72syk are non-receptor pro-
tein tyrosine kinases involved in KIIbL3-mediated sig-
nalling [19]. pp125FAK is tyrosine phosphorylated
and activated upon association with ligand-occupied
KIIbL3 and may participate in the formation of focal
adhesion complexes, which in turn play a key role
in modulating cell adhesion and shape change
[17,20,21]. However, the ligation of KIIbL3 is not suf-
¢cient to stimulate pp125FAK phosphorylation, as co-
stimulation of other signalling pathways is required
[22]. While pp125FAK has a broad pattern of tissue
expression, pp72syk is expressed exclusively in cells of
hematopoietic lineage. It has been found to be regu-
lated by both agonist and integrin receptor in a pat-
tern distinct from that of pp125FAK [23]. pp72syk has
a more proximal functional position than pp125FAK
in the ‘outside-in’ KIIbL3-mediated signalling, because
integrin ligation is a necessary and su⁄cient condi-
tion to trigger its phosphorylation.
In this study we have evaluated the e¡ect of H2O2
on platelet adhesion to immobilized ¢brinogen. We
have also evaluated whether H2O2 modulates the
levels of pp72syk and pp125FAK tyrosine phosphory-
lation promoted by KIIbL3 ligation. Since di¡erences
in the methodological approaches appear to be re-
sponsible for the con£icting results on the activity of
H2O2 on platelet functions obtained up to now, we
tested a wide range of H2O2 concentrations and we
used di¡erent experimental systems. We also studied
the e¡ect of H2O2 on ADP-induced aggregation and
dense granule secretion.
2. Materials and methods
2.1. Antibodies and chemicals
Rabbit polyclonal (LR) and mouse monoclonal
(4D10) human pp72syk antibodies were purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA); rabbit polyclonal anti-pp125FAK serum
(BC3) and anti-human pp125FAK polyclonal IgG
from Upstate Biotechnology (Lake Placid, NY,
USA); phosphotyrosine monoclonal antibody
(mAb) PT66, horseradish peroxidase-conjugated
goat anti-mouse and anti-rabbit IgG from Sigma
Chem. Co. (St. Louis, MO, USA); anti-phosphoty-
rosine mAb PY20 from Transduction Laboratories
(Lexington, KY, USA); human plasma ¢brinogen
(puritys 98%) from Calbiochem (San Diego, CA,
USA); Sepharose 2B from Pharmacia Biotech (Upp-
sala, Sweden); apyrase, H2O2, prostaglandin E1
(PGE1), ADP, orthovanadate, leupeptin, aprotinin,
phenylmethylsulfonyl £uoride, bovine serum albumin
(BSA) from Sigma Chem. Co. All other reagents
were of the highest quality available.
2.2. Preparation of platelets
Blood specimens were obtained from healthy vol-
unteers who had not taken any drugs for 9 days
before bleeding. Platelet-rich plasma (PRP) was pre-
pared from citrated (0.32% w/v) blood by centrifuga-
tion at 200Ug for 15 min. To prepare washed plate-
lets, PRP, containing 1 U/ml apyrase and 1 WM
PGE1, was further centrifuged at 1200Ug for 10
min and platelet pellet was gentle resuspended in
HEPES bu¡er, pH 7.35, containing 137 mM NaCl,
2.7 mM KCl, 1 mM MgCl2, 3 mM NaH2PO4, 5 mM
glucose, 3.5 mM HEPES and 3.5 g/l BSA. Then,
platelets were gel-¢ltered on a Sepharose 2B column
eluted with HEPES bu¡er at 1 ml/min £ow rate [24].
Platelet concentration in the column eluate (washed
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platelets) was assessed spectrophotometrically at 520
nm (1 Abs = 1.27U108 platelets/ml). Platelet suspen-
sions were diluted with HEPES bu¡er to adjust the
cell count to the appropriate concentration for ag-
gregation and adhesion assays. All procedures were
carried out at room temperature.
2.3. Platelet aggregation assay
Platelet aggregation was monitored at 37‡C on a
single channel aggregometer (Chrono-Log Aggreg-
ometer Mod. 500-CA, Haverton, PA, USA) with
continuous stirring at 900 rpm. Gel-¢ltered platelet
suspension (2.5U108 platelets/ml) was supplemented
with 0.5 mg/ml ¢brinogen, and with 5 mM Ca2. The
aggregation mixtures (250 Wl) were pre-warmed for
1 min at 37‡C before the addition of the agonist
ADP. The extent of platelet aggregation was ex-
pressed as the percentage of the light transmission,
taking as 100% the light transmission of the reference
cuvette containing the suspending bu¡er. Changes in
light transmission were recorded for at least 4 min
after the addition of the agonist. Irreversible platelet
aggregation (about 80% of light transmission) was
induced by 50 WM ADP. In the inhibition experi-
ments, platelets were pre-incubated with di¡erent
concentrations of H2O2 for 1 min or for otherwise
speci¢ed time intervals at 37‡C before adding the
agonist.
2.4. Platelet adhesion assay
Gel-¢ltered platelets were allowed to adhere to
6 cm diameter plates (Becton Dickinson, NY,
USA) or to 96-well polystyrene £at-bottom plates
(Costar Co., MA, USA) pre-coated for 16 h at 4‡C
with 1 ml/plate or 100 Wl/well of ¢brinogen solution
(100 Wg/ml). Unbound sites were blocked with 2 ml/
plate or 200 Wl/well of heat-denatured BSA (5 mg/
ml). After 1 h at 37‡C BSA was removed and plates
were washed three times with PBS. Then, the platelet
suspension (3.5U108/ml) was loaded on plates (1 ml
suspension/plate) or microtiter wells (50 Wl suspen-
sion/well). Di¡erent concentrations of H2O2 or an
equal volume of HEPES bu¡er were added to the
platelet suspension just before plating. When speci-
¢ed, platelets were pre-treated with apyrase (10 U/ml
platelet suspension) for 10 min before plating. Adhe-
sion assays were performed at room temperature.
Plates or wells coated only with BSA were used to
monitor aspeci¢c adhesion. At the established times,
non-adherent platelets were removed and the plates
or wells were washed twice with PBS. The number of
adherent platelets was measured by evaluating plate-
let endogenous acid phosphatase [25]. In details,
wells were ¢lled with 130 Wl of 50 mM sodium citrate
bu¡er, pH 5.5, containing 10 mM p-nitrophenylphos-
phate and 0.1% Triton X-100. After 1 h at 37‡C, 10
Wl of 1 N NaOH/well was added to stop the reaction
and develop the color. The plates were read at 410/
630 nm on an automated plate reader (Bio-Rad Mi-
croplate Reader, model 450). For detachment assays,
platelets were allowed to adhere to ¢brinogen for 1 h.
At the end of the attachment period, non-adherent
platelets were removed and wells were ¢lled with 25 Wl
of H2O2 or the platelet suspending bu¡er. After a
further incubation period (15 or 30 min), attached
platelets were counted as described above.
2.5. Immunoprecipitation and Western blotting
Platelets adherent to 6 cm diameter ¢brinogen-
coated plates were lysed with 600 Wl of ice-cold
RIPA bu¡er, containing 1% Triton X-100, 1% so-
dium deoxycholate, 0.1% SDS, 158 mM NaCl, 10
mM Tris^HCl, pH 7.2, 1 mM EGTA, 1 mM phenyl-
methylsulfonyl £uoride, 20 Wg/ml leupeptin, 100 kal-
likrein inactivator units/ml aprotinin, and 1 mM so-
dium orthovanadate. Plates were then taken for 30
min on ice. Platelet lysates were clari¢ed by centrifu-
gation at 14 000 rpm for 10 min in a refrigerated
(+4‡C) microfuge. The resulting supernatants were
characterized for protein concentration by Bio-Rad
DC protein assay (Bio-Rad Laboratories, Hercules,
CA, USA). A spectrophotometrically checked BSA
solution in RIPA bu¡er was taken as standard. Ly-
sates were stored at 320‡C until use.
Lysates containing equal amounts of proteins were
immunoprecipitated with the ant-pp125FAK BC3
antiserum (2 Wg/200 Wg proteins) or with the anti-
pp72syk LR antiserum (2 Wl/300 Wg proteins) and
protein A/G-agarose overnight at 4‡C. Beads were
sedimented by brief centrifugation and washed exten-
sively with ice-cold RIPA bu¡er. Proteins, solubilized
in boiling SDS sample bu¡er (2% SDS, 1% L-mer-
captoethanol, 66 mM Tris, pH 7.5, 10 mM EDTA),
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were separated on a 7.5% or 10% SDS-polyacryl-
amide gel and transferred to nitrocellulose. The blots
were incubated for 1 h at 42‡C in blocking solution
(5% BSA, 170 mM NaCl, 0.2% Nonidet P-40, 50
mM Tris, pH 7.5), washed with blocking solution
without BSA, and probed for 2 h with anti-phospho-
tyrosine mAb PT66 (1:10 000). The blots were
washed three times, incubated for 2 h with horserad-
ish peroxidase-conjugated secondary antibodies
(1:3000 in 3% BSA blocking solution) and the im-
munoreactive bands were visualized by enhanced
chemiluminescence kit (Amersham Corp., Bucking-
hamshire, UK). To monitor loading of gel lanes,
blots were stripped by incubation for 30 min at
70‡C with a solution containing 2% SDS, 62.5 mM
Tris^HCl, pH 6.7, 100 mM L-mercaptoethanol and
then re-probed with the anti-human pp125FAK
(1:500) or anti-pp72syk (4D10) (1:200) antibodies;
the membranes were blocked with 5% not-fat dry
milk at 25‡C. Quantitation of proteins was per-
formed by densitometry using a Discover Pharmacia
scanner equipped with a sun spark classic densito-
metric workstation.
2.6. Luminescence experiments
Platelets (2.5^3U108 platelets/ml) were pre-incu-
bated for 3 min with the ATP-detecting system luci-
ferin-luciferase (Chrono-lume reagent, Chrono-Log)
before adding ADP and/or H2O2. ATP secretion was
assessed by arbitrarily setting at 0% the luminescence
of resting platelets and at 100% that of ADP-stimu-
lated platelets. Chemiluminescence tracings were fol-
lowed simultaneously with the aggregation ones.
2.7. Cytotoxicity assay
Toxicity of H2O2 was evaluated by measuring the
extent of lactate dehydrogenase (LDH) released by
washed platelets (3U108 platelets/ml) after their ex-
posure for 1 h to increasing doses of H2O2 (up to
1 mM). Control platelets and H2O2-treated platelets
were collected by centrifugation at 11 000 rpm for
10 s. LDH activity was expressed as the amount of
NADH/min formed after the addition of pyruvate
and NAD to supernatants of samples and controls
[26]. Total LDH content was measured after platelet
lysis by sonication.
3. Results
3.1. H2O2 does not a¡ect platelet adhesion to
immobilized ¢brinogen
The adhesion of platelets to immobilized ¢brino-
gen occurs without the need for any stimulation in-
duced by agonists [16]. Unstimulated platelets have
been shown to adhere to ¢brinogen-coated plates
also in the presence of apyrase, which inactivates
the endogenous agonist ADP released from dense
granules [22]. Apyrase-treated platelets represent a
useful tool to study the e¡ect of H2O2 on platelet
KIIbL3-mediated adhesion, since it allows one to
avoid any interfering agonist-induced conformational
change of the integrin receptor.
Both control and apyrase-treated platelets were ex-
posed to increasing doses of H2O2 during the whole
time of adhesion to ¢brinogen-coated plates. The
concentration of H2O2 dilutions, which were pre-
pared daily, was assessed spectrophotometrically us-
ing the following extinction coe⁄cient: OV254 = 43.6
M31 cm31. The concentration of H2O2 did not sig-
ni¢cantly change during the adhesion experiments as
measured by evaluating the absorption spectrum of
H2O2 solutions taken on a plate for 1 h: it was
qualitatively and quantitatively comparable to that
obtained with the same solution before the incuba-
tion. The doses of H2O2 employed (0.01^1 mM) were
not toxic for platelets. In fact, the amount of LDH
released in the suspending bu¡er by platelets exposed
for 1 h to H2O2 concentrations up to 1 mM was
comparable to that produced by control platelets in-
cubated for the same time interval (6 18 nmol
NADH/3U108 platelets/min). The amount of total
releasable LDH was 936 þ 41 nmol NADH/3U108
platelets/min.
Under these experimental conditions, we found
that the presence of H2O2 did not a¡ect the number
of platelets adhering to ¢brinogen-coated dishes.
This result was independent of the adhesion time
and was observed in the whole range of tested
H2O2 doses (Table 1). The same results were ob-
tained with apyrase-treated platelets adhering to ¢-
brinogen for 30 min, whereas only a slight decrease
(about 20%) of the number of adherent platelets was
observed when apyrase-treated platelets were ex-
posed to 1 mM H2O2 for 60 min (Table 1).
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The lack of anti-adhesive activity of H2O2 was
con¢rmed by detachment experiments. Control and
apyrase-treated platelets were allowed to adhere to
¢brinogen for 1 h and then exposed to H2O2 or to
the suspending bu¡er for a further 15 or 30 min. At
the end of the incubation period, no di¡erences in
the number of adherent platelets were observed be-
tween samples treated with H2O2 doses up to 1 mM
or the bu¡er alone (data not shown).
3.2. H2O2 does not a¡ect pp72syk phosphorylation,
whereas it modulates pp125FAK phosphorylation
in ¢brinogen-adherent platelets
The binding of KIIbL3 to solid-phase ¢brinogen
promotes an increase in tyrosine phosphorylation
of several proteins [27]. The ability of H2O2 to mod-
ulate the transduction events induced by integrin li-
gation was evaluated by measuring the e¡ect of
H2O2 on the levels of phosphorylation of pp72syk
and pp125FAK, two tyrosine kinases activated down-
stream of KIIbL3 engagement [19]. Platelets were al-
lowed to adhere to ¢brinogen for di¡erent time in-
tervals in the presence of a wide range of H2O2 doses
(0.01^1 mM). Non-adherent platelets exposed to
BSA-coated surfaces were used as controls. Equal
amounts of detergent-extracted proteins were then
subjected to immunoprecipitation and Western blot-
ting experiments.
Firstly we analyzed the e¡ect of H2O2 on the phos-
phorylation of pp72syk, which is activated in an early
phase of integrin signalling. The levels of pp72syk
phosphorylation were unchanged after the exposure
of platelets to all tested H2O2 concentrations as com-
pared to the levels of untreated platelets. Fig. 1A
Table 1
Platelet adhesion to ¢brinogen-coated wells in the absence and in the presence of di¡erent H2O2 concentrations
H2O2 concentration (mM) Adhesion time (min) Number of adherent platelets (U106)
3apyrase +apyrase
None 30 1.92 þ 0.25 1.76 þ 0.19
60 2.50 þ 0.36 2.20 þ 0.31
0.01 mM 30 2.09 þ 0.22 1.78 þ 0.23
60 2.36 þ 0.35 2.17 þ 0.23
0.1 mM 30 1.82 þ 0.26 1.72 þ 0.18
60 2.52 þ 0.40 2.25 þ 0.36
1 mM 30 1.98 þ 0.29 1.45* þ 0.17
60 2.38 þ 0.39 1.77* þ 0.19
Gel-¢ltered control and apyrase-pretreated platelets (3.5U108 platelets/ml) were allowed to adhere to 96-well plates for 30 and 60 min
either in the absence or in the presence of di¡erent amounts of H2O2. Non-adherent platelets were removed and the number of adher-
ent platelets was measured by evaluating platelet endogenous phosphatase as described in Section 2. Data reported are the mean val-
ues calculated on 10 measures for each of three di¡erent experiments.
*P6 0.05 as compared with control by Student’s two-tailed t-test.
Fig. 1. H2O2 activity on pp72syk phosphorylation. Fibrinogen-
adherent platelets were lysed and immunoprecipitated with anti-
pp72syk antibody (LR). The immunoprecipitates were subjected
to 7.5% (A) or 10% (B) SDS electrophoresis. After Western
blotting, tyrosine-phosphorylated proteins were visualized by
mAb PT66 (A and B, upper blots). Data reported in A and B
have been obtained in two separate experiments, each per-
formed at least twice. (A) Control platelets adhering to ¢brino-
gen for 60 min in the absence (lane 2) and in the presence of
0.01 mM H2O2 (lane 3), 0.1 mM H2O2 (lane 4) and 1 mM
H2O2 (lane 5). The immunoprecipitate from platelets adhering
to BSA-coated plates is in lane 1. (B) Platelets adhering to ¢-
brinogen for 30 min in the absence (lane 1) and in the presence
of 0.1 mM H2O2 (lane 2) and 1 mM H2O2 (lane 3). Positions
of molecular markers (in kDa) and pp72syk (arrows) are indi-
cated. The amount of pp72syk loaded was equal in all lanes as
was veri¢ed on parallel immunoblots probed with the anti-
pp72syk antibody (4D10) (A and B, lower blots).
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(upper blot) reports the results obtained with plate-
lets adhering to ¢brinogen for 60 min in the absence
and in the presence of 0.01, 0.1 and 1 mM H2O2.
pp72syk phosphorylation also occurred, though to a
lesser extent, in platelets attached to BSA-coated
plates (Fig. 1A, lane 1). H2O2 was ine¡ective in mod-
ulating pp72syk phosphorylation also in experiments
performed on platelets adhering to ¢brinogen for a
time shorter than 60 min. This ¢nding is summarized
in Fig. 1B (upper blot), where are reported the levels
of pp72syk phosphorylation measured in platelets ad-
hering to ¢brinogen for 30 min in the absence and in
the presence of 0.1 mM and 1 mM H2O2.
Then we evaluated the e¡ect of H2O2 on pp125FAK
phosphorylation. The levels of pp125FAK phosphor-
ylation measured in platelets adhering to ¢brinogen
for 60 min were reduced by H2O2. The inhibitory
e¡ect was detectable at H2O2 doses higher than 0.1
mM and was dose-dependent (Fig. 2, upper blot).
H2O2 concentrations ranging from 0.01 mM to
0.05 mM failed to a¡ect pp125FAK phosphorylation
(data not shown). No pp125FAK phosphorylation
was observed in BSA-attached platelets (Fig. 2,
lane 5). Further experiments were performed to eval-
uate the e¡ect of H2O2 on pp125FAK phosphoryla-
tion at adhesion times shorter than 60 min. In agree-
ment with our previous observations [28], pp125FAK
phosphorylation increased as a function of the time
of platelet adhesion to immobilized ¢brinogen, being
1.5-fold higher at 60 min than at 30 min (data not
shown). The inhibitory potency of H2O2 on
pp125FAK activation was independent of the adhe-
sion time. In fact, the ratio between the intensity of
the phosphorylated pp125FAK signals obtained with
platelets exposed to 1 mM H2O2 and that from con-
trol platelets was about 0.20 in either 30 or 60 min
adhesion experiments.
The results of the experiments described above
demonstrate a dose-dependent inhibitory activity of
H2O2 on one or more of the signal transduction
events responsible for pp125FAK phosphorylation.
However, using a di¡erent experimental model,
where pp125FAK phosphorylation is inhibited, we
found that H2O2 can also induce a ‘co-stimulus’ for
these signal transduction events. pp125FAK phos-
phorylation is abolished by platelet pre-treatment
with apyrase [22]. Apyrase inactivates ADP and
thus inhibits the ADP-dependent transduction sig-
nals which, co-operating with those triggered by
the occupied integrin, lead to pp125FAK activation.
However, the addition of 1 mM of the weak agonist
epinephrine to apyrase-treated platelets completely
restores pp125FAK phosphorylation in this experi-
mental model [22]. We used apyrase-treated platelets
to evaluate whether H2O2, like epinephrine, might be
able to re-establish pp125FAK phosphorylation by
activating the same transduction pathways blocked
by apyrase treatment or by stimulating alternative
ones. Apyrase-treated platelets were allowed to ad-
here to ¢brinogen-coated plates for 60 min in the
absence or in the presence of di¡erent amounts of
H2O2 and lysates were subjected to immunoprecipi-
tation and Western blotting experiments. While epi-
nephrine addition to apyrase-treated platelets pro-
moted a strong pp125FAK phosphorylation, H2O2
failed to reverse the inhibitory e¡ect of apyrase, since
no pp125FAK phosphorylation was detectable in
apyrase-treated platelets exposed to H2O2 doses
ranging from millimolar to micromolar concentra-
tions (Fig. 3, upper blot).
It has been reported that H2O2 can act synergisti-
cally with agonists in activating platelet response
[10]. To test this possibility in our system, apyrase-
treated platelets were exposed simultaneously to a
Fig. 2. Dose-dependent inhibition of pp125FAK phosphorylation
by H2O2. Unstimulated platelets adhering to ¢brinogen in the
absence (lane 1) and in the presence of 0.1 mM H2O2 (lane 2),
0.5 mM H2O2 (lane 3) and 1 mM H2O2 (lane 4) for 60 min
were lysed and immunoprecipitated with anti-pp125FAK anti-
body (BC3). The immunoprecipitate from platelets adhering to
BSA-coated plates is in lane 5. The immunoprecipitates were
subjected to 7.5% SDS electrophoresis. After Western blotting,
tyrosine-phosphorylated proteins were visualized by mAb PT66
(upper blot). Positions of molecular markers (in kDa) and
pp125FAK (arrows) are indicated. The amount of pp125FAK
loaded was equal in all lanes as was veri¢ed on parallel immu-
noblots probed with the polyclonal anti-human pp125FAK anti-
body (lower blot). Data here reported have been con¢rmed in
three separate experiments of equal design.
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subthreshold dose (0.05 WM) of epinephrine, i.e. a
dose unable to completely re-establish pp125FAK
phosphorylation, and to di¡erent concentrations of
H2O2 (in the range 1 WM^1 mM). Under these ex-
perimental conditions, we found that only H2O2
doses near to physiological values (10^20 WM) were
able to restore pp125FAK phosphorylation (Fig. 4,
upper blot). No pp125FAK phosphorylation was de-
tected in apyrase-treated platelets exposed to 0.05
WM epinephrine and H2O2 concentrations either low-
er than 5 WM or higher than 0.05 mM (data not
shown). The lack of the co-agonist activity of H2O2
at doses higher than 0.05 mM may be ascribed to an
overlapping of inhibitory and stimulatory e¡ects of
H2O2 on platelet signalling.
3.3. H2O2 inhibits platelet aggregation and dense
granule secretion
Gel-¢ltered platelets were pre-incubated for 1 min
at 37‡C with H2O2 before the addition of ADP. No
changes in light transmission were recorded during
this pre-incubation period, indicating that, under our
experimental conditions, H2O2 does not show any
pro-aggregating activity. Platelet exposure to H2O2
doses higher than 0.1 mM reduced the extent of
ADP-induced aggregation, whereas lower concentra-
tions did not a¡ect the process. The inhibitory e¡ect
of H2O2 was dose-dependent and was more pro-
nounced on the second wave than on the ¢rst (Fig.
5). In another set of experiments we found that the
inhibitory potency of H2O2 increased with increasing
pre-incubation time with platelets. When platelets
were exposed for 1, 3 and 5 min to a ¢xed dose of
H2O2 (0.5 mM), the extent of aggregation, measured
2 min after the agonist addition, was reduced by 31,
48 and 62%, respectively.
Since the lack of the second wave of aggregation is
indicative of an impairment of the late events of the
aggregation process, such as secretion, we evaluated
whether H2O2 a¡ects this process. The ATP release,
in response to platelet stimulation, was evaluated
with the luciferin-luciferase system and was followed
simultaneously with aggregation. In agreement with
data previously reported [11], we found that doses of
H2O2 which inhibited platelet aggregation also inhib-
ited the nucleotide release. In particular, 0.5 and
1 mM H2O2 caused a 39% and 67%, respectively,
decrease of the amount of ATP released 2 min after
the start of aggregation.
Fig. 4. Induction of pp125FAK tyrosine phosphorylation by
H2O2 and subthreshold amounts of epinephrine in apyrase-
treated platelets. Apyrase-treated platelets were allowed to ad-
here for 60 min to immobilized ¢brinogen in the absence and
in the presence of di¡erent stimuli. Platelet lysates were immu-
noprecipitated with anti-pp125FAK antibody (BC3) and the im-
munoprecipitates were subjected to 7.5% SDS electrophoresis.
After Western blotting, tyrosine-phosphorylated proteins were
visualized by mAb PT66 (upper blot). Lane 1, platelets plus
1 mM epinephrine; lane 2, plus 0.01 mM H2O2 ; lane 3, plus
0.05 WM epinephrine; lane 4, plus 0.05 WM epinephrine and
0.01 mM H2O2 ; lane 5, plus 0.02 mM H2O2 ; lane 6, plus 0.05
WM epinephrine and 0.02 mM H2O2. Positions of molecular
markers (in kDa) and pp125FAK (arrows) are indicated. The
amount of pp125FAK loaded was equal in all lanes as was veri-
¢ed on a parallel immunoblot probed with the antibody against
pp125FAK (lower blot). Data reported in this ¢gure have been
con¢rmed in three separate experiments.
Fig. 3. E¡ect of H2O2 on tyrosine phosphorylation of
pp125FAK in apyrase-treated platelets. Apyrase-treated platelets
were allowed to adhere for 60 min to ¢brinogen-coated plates
in the absence and in the presence of di¡erent stimuli. After the
adhesion period, platelets were lysed and immunoprecipitated
with anti-pp125FAK antibody (BC3). The immunoprecipitates
were subjected to 7.5% SDS electrophoresis. After Western
blotting, tyrosine phosphorylated proteins were visualized by
mAb PT66 (upper blot). Lane 1, platelets alone; lane 2, plus
1 mM epinephrine; lane 3, plus 0.01 mM H2O2 ; plus 0.1 mM
H2O2 ; lane 4, plus 1 mM H2O2. Positions of molecular
markers (in kDa) and pp125FAK (arrow) are indicated. The
amount of pp125FAK loaded was equal in all lanes as was veri-
¢ed on a parallel immunoblot probed with the antibody against
pp125FAK (lower blot). Data reported in this ¢gure have been
con¢rmed in three separate experiments of equal design.
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4. Discussion
A growing body of evidence demonstrates that
oxygen reactive species may act as fundamental sig-
nalling molecules in many cellular processes [1^3].
H2O2 has been shown to stimulate tyrosine and or
serine/threonine protein phosphorylation [29,30], to
induce an increase of the intracellular level of Ca2
[31] and to act as a second messenger [32]. In this
study we evaluated whether H2O2 interferes with the
capability of platelets to bind immobilized ¢brinogen
and with the subsequent post-ligand transduction
events, such as pp72syk and pp125FAK phosphoryla-
tion.
Fibrinogen in vivo can be immobilized on the sur-
face of activated platelets and also deposited within
the vessel wall at the site of vascular injury [33].
KIIbL3 is the functional integrin receptor which medi-
ates selective and irreversible platelet adhesion to
solid-phase ¢brinogen. Under our experimental con-
ditions, a large range of H2O2 concentrations does
not a¡ect the extent of platelet adhesion to ¢brino-
gen-coated plates (Table 1). The binding of KIIbL3 to
immobilized ¢brinogen does not require agonist-in-
duced activation of the integrin, but it depends only
upon the integrity of the complementary recognition
sequences present in the molecules of these two pro-
teins [16]. Thus, the lack of any e¡ect of H2O2 on the
KIIbL3-¢brinogen recognition and binding indicates
that H2O2, at a molecular level, does not cause any
structural modi¢cations of either ¢brinogen or its
receptor. However, a prolonged exposure of platelets
to a high dose of H2O2 (1 mM) causes a slight de-
crease of apyrase-treated platelet attachment to im-
mobilized ¢brinogen. This result could be ascribed to
structural modi¢cations of ¢brinogen induced by the
oxidative conditions. In a previous study we showed
that oxidative modi¢cations reduce the ¢brinogen
capability to support the adhesion of unstimulated
platelets [34].
While integrin-immobilized ¢brinogen binding oc-
curs in the absence of any stimulus, being a simple
protein^protein interaction, several post-ligand trans-
duction events are required for full platelet activation
and spreading. Millimolar concentrations of H2O2
inhibit, at least in part, protein tyrosine phosphory-
lation triggered by KIIbL3 engagement. In particular,
our results demonstrate that H2O2 does not a¡ect the
tyrosine phosphorylation of the early activated pro-
tein pp72syk (Fig. 1), but it reduces the extent of
phosphorylation of pp125FAK (Fig. 2), which is phos-
phorylated in a later phase of the occupied integrin-
induced signalling. These ¢ndings con¢rm that
pp72syk and pp125FAK do not depend on each other
for their activation and that the signalling pathways
required for pp125FAK phosphorylation di¡er from
those needed for pp72syk phosphorylation [23]. A
stimulatory activity of H2O2 on pp72syk phosphory-
lation has been previously described [35^38]. How-
ever, in these studies the tested doses of H2O2 were
higher than those used by us [35,37]; further, H2O2
Fig. 5. Inhibition of platelet aggregation by H2O2. Platelets
were preincubated at 37‡C for 1 min with H2O2 before the ad-
dition of 50 WM ADP (arrow). Aggregation tracings: 1, control
platelets ; 2, plus 0.3 mM H2O2 ; 3, plus 0.5 mM H2O2 ; 4, plus
1 mM H2O2. Chart speed was 1 cm/min. Data reported are
from one experiment representative of three experiments per-
formed in duplicate.
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was tested in combination with vanadate, a phospha-
tase inhibitor [36,38].
pp72syk is phosphorylated on tyrosine immediately
after KIIbL3 ligation to immobilized ¢brinogen,
whereas co-ordinate signalling induced by the occu-
pied integrin and by endogenous agonists, released
during adhesion, must converge within the cell to
lead to pp125FAK phosphorylation [22]. H2O2 does
not show any e¡ect on either KIIbL3-¢brinogen bind-
ing or the early transduction signals following integ-
rin ligation. Thus, H2O2 might reduce the extent of
pp125FAK phosphorylation by inhibiting the addi-
tional signalling pathways elicited by the ADP bind-
ing to its receptor. Actually the inhibition of the
post-receptorial cascade might depend on the capa-
bility of H2O2 to interfere with one or both of the
following sequential events: (i) endogenous ADP re-
lease reaction; (ii) binding of ADP to its heptahelical
receptor.
The results obtained from aggregation and lumi-
nescence experiments may be of help to establish the
contribution of these two mechanisms to the H2O2
inhibitory action. We found that H2O2 doses which
are e¡ective in reducing pp125FAK phosphorylation
are also able to inhibit both aggregation and dense
granule secretion in ADP-stimulated platelets (Fig.
5). We used the aggregation system, instead of the
adhesion assay, to evaluate the capability of H2O2 to
impair the release reaction, since it has been reported
that in the medium of ¢brinogen-adherent platelets
there are no detectable amounts of agonist released
from dense granules [27]. Aggregation tracings (Fig.
5) show that the inhibitory e¡ect of H2O2 is more
pronounced on the second wave of the process and
that the inhibitory potency of H2O2 increases as a
function of its pre-incubation time with platelets.
These experimental data suggest that H2O2 interferes
mainly with post-receptorial aggregation events.
However, a reduction of ADP receptor binding af-
¢nity might also occur as a consequence of H2O2
platelet treatment. This supports previous observa-
tions by Ohyashiki et al., demonstrating a reduced
binding for ADP in platelets exposed to H2O2 [9].
Even though most studies demonstrate the ability
of H2O2 to positively modulate protein phosphory-
lation in several cellular systems [29,35^38], our data
show an inhibitory rather than a stimulatory action
of H2O2 on this process. However, using a restrictive
experimental model in which pp125FAK phosphory-
lation is completely abolished, we were able to
demonstrate a co-stimulatory activity of H2O2
on transduction signals involved in pp125FAK
phosphorylation. Platelets treated with apyrase,
which blocks signals downstream of ADP receptor
binding, do not show any pp125FAK phosphorylation
[22]. The addition to the apyrase-treated platelet sys-
tem of agonists able to re-activate these signals, or
alternative ones, restores pp125FAK phosphorylation.
The weak agonist epinephrine is able to re-establish
pp125FAK phosphorylation [22] and the activation of
arachidonic acid metabolism has been proposed as
the mechanism by which it overcomes the consequen-
ces of endogenous ADP inactivation [39]. Several
lines of evidence suggest that H2O2 can also stimu-
late arachidonic acid metabolism either by activating
phospholipase A2 [40] or by promoting the synthesis
of arachidonic acid metabolites, such as thrombox-
ane [11]. Furthermore, H2O2 has been shown to ac-
tivate protein kinase C [41], which plays a central
role in the transduction pathway responsible for
pp125FAK phosphorylation [42]. Despite the potential
agonist-mimetic properties, H2O2 fails to restore
pp125FAK phosphorylation when added alone to
apyrase-treated platelets (Fig. 3). However, phos-
phorylated pp125FAK can be detected when platelets
are exposed simultaneously to H2O2 doses near to
physiological values and to a subthreshold dose of
epinephrine (Fig. 4). This property of H2O2 to act as
a co-agonist by strengthening the e¡ect of subthresh-
old concentrations of epinephrine has been already
reported in a previous study, where H2O2 was able to
trigger the aggregation of platelets primed with sub-
threshold doses of exogenous agonists [43].
The data reported here highlight a dose-dependent
discrepancy between inhibitory and stimulatory ac-
tivity of H2O2 on signalling events triggered by plate-
let adhesion to ¢brinogen. The inhibitory e¡ect of
H2O2 on signals required for pp125FAK phosphory-
lation does not appear to be of physiological rele-
vance as it occurs at concentrations of the chemical
far from those occurring in vivo. Previously a close
association has been found between leukocytes and
platelets during thrombus generation [4]. Interest-
ingly, the property of H2O2 to act synergically with
subthreshold doses of epinephrine in inducing
pp125FAK phosphorylation is observed with amounts
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of H2O2 near to those released in vivo by activated
leukocytes (10^12 WM) [44]. The initial platelet con-
tact with immobilized ¢brinogen, which in vivo can
be localized at the site of vascular lesions by absorp-
tion from plasma and/or by formation of insoluble
¢brin, raises a cascade of transduction signals which
lead to platelet spreading. Since this structural and
functional modi¢cation of platelets is strictly associ-
ated with pp125FAK phosphorylation [22], our results
on the capability of H2O2 to modulate the phosphor-
ylation of this protein suggest that H2O2 might play
a role in physiological hemostasis and/or in throm-
bus generation.
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